{
    "clinical_study": {
        "@rank": "35112", 
        "arm_group": [
            {
                "arm_group_label": "Best Medical Therapy", 
                "arm_group_type": "No Intervention", 
                "description": "Participants will follow standard post-transplant protocols with IPC"
            }, 
            {
                "arm_group_label": "Geko device", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will be fitted with the device to ensure that it functions according to the manufacturer's instructions by a trained technician. This device will be changed every 24 hours. The device is worn on both legs and is worn for 24 hours a day. The device will first be put on the first day following the day of surgery and will then be changed the following day at the same time for a total of 7 days after surgery."
            }
        ], 
        "brief_summary": {
            "textblock": "This will be a randomized, controlled trial involving kidney and kidney pancreas transplant\n      patients. There will be 2 groups and patients will be randomized to one of the two; one will\n      receive standard of care IPC or TED stockings to help with circulation, the other group will\n      use the geko device which is a newer device with Health Canada approval. Clinical outcomes\n      will be compared for those in each group and clinical differences between patients who\n      receive routine medical therapy with IPC/TEDS versus the Geko device will also be evaluated."
        }, 
        "brief_title": "The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema", 
        "condition": [
            "Kidney Transplant", 
            "Kidney Pancreas Transplant", 
            "Edema"
        ], 
        "condition_browse": {
            "mesh_term": "Edema"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female\n\n          -  At least 18 years old\n\n          -  Undergoing kidney or kidney pancreas transplant surgery as the recipient\n\n          -  Able and willing to provide written informed consent\n\n          -  Absence of known peripheral vascular disease\n\n          -  Body Mass Index of between 18 and 34\n\n          -  Leg circumference at site of geko\u2122 device placement is 24\" or less\n\n        Exclusion Criteria:\n\n          -  History of deep vein thrombosis\n\n          -  Temporary or permanent cardiac pacing\n\n          -  Patient is pregnant\n\n          -  Any patient which may be excluded by way of warnings in the Manufacturer's\n             Instructions for Use\n\n          -  Any patient who requires an ECG electrode applied on the leg for continuous\n             monitoring throughout therapy\n\n          -  Previous leg(s) amputation\n\n          -  Presence of any of the following in the site of intended device placement: cancerous\n             lesion, swollen or infected or inflamed areas or skin eruptions i.e. phlebitis,\n             thrombophlebitis, varicose veins\n\n          -  History or signs of haematological disorders (especially in relation to clotting or\n             coagulation disorders) including presence or history of thrombus formation\n\n          -  BMI index >36\n\n          -  Patients with any neurological disorder or disease that would interfere with proper\n             assessment and or conduct of the trial\n\n          -  History of implantable brain or other stimulator\n\n          -  Patients who can not tolerate the stimulation from the GEKO device"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860820", 
            "org_study_id": "103618"
        }, 
        "intervention": {
            "arm_group_label": "Geko device", 
            "intervention_name": "Geko device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "IPC/TEDS", 
            "Geko device"
        ], 
        "lastchanged_date": "May 22, 2013", 
        "location": {
            "contact": {
                "email": "alp.sener@lhsc.on.ca", 
                "last_name": "Alp Sener, MD", 
                "phone": "519-685-8500", 
                "phone_ext": "33352"
            }, 
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N6A 5A5"
                }, 
                "name": "London Health Sciences Centre, University Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Neuromuscular Stimulation on Post-Transplant Leg Edema", 
        "other_outcome": {
            "description": "Diuretic use wil be tracked for participants in each of the arms to assess wither there is a difference.", 
            "measure": "Use of diuretics", 
            "safety_issue": "No", 
            "time_frame": "Within 30 days of transplant"
        }, 
        "overall_contact": {
            "email": "alp.sener@lhsc.on.ca", 
            "last_name": "Alp Sener, MD", 
            "phone": "519-685-8500", 
            "phone_ext": "33352"
        }, 
        "overall_official": {
            "affiliation": "Lawson Health Research Institute, London Health Sciences Centre", 
            "last_name": "Alp Sener, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Canada: Research Ethics Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "As measured by patient weight and leg diameter", 
            "measure": "Decrease in edema", 
            "safety_issue": "No", 
            "time_frame": "Within 30 days post-transplant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860820"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Lawson Health Research Institute", 
            "investigator_full_name": "Alp Sener", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Patients will be asked to complete a questionnaire at these time points to assess their satisfaction", 
            "measure": "Patient satisfaction", 
            "safety_issue": "No", 
            "time_frame": "3 and 6 days after transplant"
        }, 
        "source": "Lawson Health Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lawson Health Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}